Boehringer Ingelheim B.V.

Netherlands · Reporting entity ID 100000010618

Total reported 2019–2025

$156K

#1,996 of 2,960 reporting companies — 0% of all reported industry payments

$129K in general payments across 22 records, plus $27K in research funding across 86 records.

How it breaks down

General payments $129,191

Research funding $26,999

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.